“Takeda’s commitment to creating and preserving value through environmental, social and governance initiatives is an important part of our role as a patient-centric and values-based global biopharmaceutical leader,” said Christophe Weber, President and CEO. “We understand the significance of sustainable business practices, and we are proud to be recognized for Takeda’s global impact and long-term commitment to building a brighter future.”
While our efforts to make the business more sustainable are ongoing and expansive, as detailed in our 2018 Sustainable Value Report, Takeda scored especially high in the Dow Jones Sustainability Indices for our work in protecting the environment and improving access to medicines for our patients.
Takeda continued to rank higher than the industry average for our environmental protection activities, which we believe are essential in delivering Better Health and a Brighter Future for all.
We view our environmental responsibilities as critical to our ability to act according to our four core values of Integrity, Fairness, Honesty and Perseverance. We consider the impact of our operations on the environment and are working to be responsible stewards of our natural resources, setting ambitious goals to reduce our greenhouse gas emissions, water use and waste going to landfill.
Takeda's commitment to conservation and the environment goes back decades. In addition to our initiatives aimed at combatting climate change and water scarcity, we are proud of our work to uphold the biodiversity of natural habitats, which are home to vital resources used in the research and development of innovative medicines.
Beyond our conservation efforts, Takeda is also working with suppliers to improve the sustainability of our entire value chain. In 2015, we joined the Pharmaceutical Supply Chain Initiative (PSCI), which provides collaborative and educational opportunities for companies and suppliers in the industry. Today, hundreds of suppliers have been through our rigorous screening process based on the PSCI principles for environmental stewardship.
Another area where Takeda ranked highly in the Dow Jones Sustainability Indices was our strategy to increase access to medicines for complex and rare diseases in countries that lack strong healthcare systems, where there are significant unmet patient needs and affordability barriers due to the difficulty in diagnosing, treating and managing these conditions. In fact, the company scored more than three times the average for the pharmaceutical industry.
Recognitions such as the Dow Jones Sustainability Indices reflect what Takeda has already achieved and what we are looking forward to continuing to do.
As we work toward our 2020 environmental goals and Better Health and a Brighter Future for all, we are developing new sustainability targets for fiscal 2030 that will continue to reflect and embody our four core values – Integrity, Fairness, Honesty and Perseverance.
For more information on Takeda's sustainability efforts and results, visit Takeda.com/corporate-responsibility/.